Evidence map›Paper›PMID 25690100›Full record

ArticleInfection and immunity2015

Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response.

Kimberley L Painter, Elizabeth Strange, Julian Parkhill, Kathleen B Bamford, Darius Armstrong-James, Andrew M Edwards

Open access · hybridAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Article
  3. Metabolic reprogramming promotesMicrobiology (Reading, England) · 2026
    Article
  4. mSphere · 2026
    Article
  5. Article
  6. Article
  7. Biofilm-associated genes inFrontiers in microbiology · 2026
    Review
  8. Iodinated BODIPY-C₆₀ systems bearing bis-phosphonate groups for antimicrobial PDT.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  9. Article
  10. Review
  11. Journal of bacteriology · 2025
    Article
  12. Defects in anaplerotic metabolism sensitizeMicrobiology spectrum · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Phenotypic Variation inAntibiotics (Basel, Switzerland) · 2024
    Review
  18. mLife · 2024
    Review
  19. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  20. Photodynamic treatment ofRSC medicinal chemistry · 2024
    Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kimberley L PainterMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Elizabeth StrangeMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Julian ParkhillWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-7069-5958
Kathleen B BamfordDepartment of Microbiology, Hammersmith Campus, Imperial College Healthcare NHS Trust, London, United Kingdom.
Darius Armstrong-JamesDepartment of Medicine, Imperial College London, London, United Kingdom.
Andrew M EdwardsMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom a.edwards@imperial.ac.uk.ORCID http://orcid.org/0000-0002-7173-7355
Biology of Infection · FRImperial College London · GBImperial College Healthcare NHS Trust · GBWellcome Sanger Institute · GB

Funding

Medical Research Council G0902260Medical Research Council MR/J006874/1NIAID NIH HHS HHSN272200700055C
6 · The paper itself

Abstract

The development of chronic and recurrent Staphylococcus aureus infections is associated with the emergence of slow-growing mutants known as small-colony variants (SCVs), which are highly tolerant of antibiotics and can survive inside host cells. However, the host and bacterial factors which underpin SCV emergence during infection are poorly understood. Here, we demonstrate that exposure of S. aureus to sublethal concentrations of H2O2 leads to a specific, dose-dependent increase in the population frequency of gentamicin-resistant SCVs. Time course analyses revealed that H2O2 exposure caused bacteriostasis in wild-type cells during which time SCVs appeared spontaneously within the S. aureus population. This occurred via a mutagenic DNA repair pathway that included DNA double-strand break repair proteins RexAB, recombinase A, and polymerase V. In addition to triggering SCV emergence by increasing the mutation rate, H2O2 also selected for the SCV phenotype, leading to increased phenotypic stability and further enhancing the size of the SCV subpopulation by reducing the rate of SCV reversion to the wild type. Subsequent analyses revealed that SCVs were significantly more resistant to the toxic effects of H2O2 than wild-type bacteria. With the exception of heme auxotrophs, gentamicin-resistant SCVs displayed greater catalase activity than wild-type bacteria, which contributed to their resistance to H2O2. Taken together, these data reveal a mechanism by which S. aureus adapts to oxidative stress via the production of a subpopulation of H2O2-resistant SCVs with enhanced catalase production.

Indexed as

Adaptation, BiologicalOxidative StressSOS Response, GeneticsCatalaseDNA-Directed DNA PolymeraseHydrogen PeroxideRecombinasesStaphylococcus aureusCatalaseDNA-Directed DNA PolymeraseHydrogen PeroxideRecombinases

Identifiers

PMID25690100
PMCPMC4399076
OpenAlexW2152920782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.